Healthcare

Hospitals, clinics, payers, med‑tech, telehealth, and healthcare services delivery.

  • 9 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Healthcare


quiverquant.com > news > Insider+Sale:+Director+at+$ELMD+Sells+3,562+Shares

Insider Sale: Director at $ELMD Sells 3,562 Shares

2+ hour, 4+ min ago   (175+ words) KATHLEEN SKARVAN, a director at $ELMD, sold 3,562 shares of the company on 05-15-2026 for an estimated $132,969. We received data on the trade from a recent SEC filing. This was a sale of approximately 9.1% of their shares of this class of stock....


sg.finance.yahoo.com > news > cvs-health-cvs-opens-pharmacy-021020353.html

CVS Health (CVS) Opens New Pharmacy Sites As Undervalued Narrative Holds

58+ min ago   (412+ words) CVS Health (CVS) is expanding its pharmacy-focused format by opening nearly 20 smaller neighborhood locations across the US in 2026, including a new Roxbury site in the Boston area. Recent headlines around CVS Health have mixed signals for investors, with Medicare Advantage…...


nst.com.my > news > nation > 10/15/20/26/52877 > mma-end-contract-doctor-system-better-pay-fairer-postings

MMA: End contract doctor system with better pay, fairer postings

18+ min ago   (17+ words) End contract doctor system with better pay, fairer postings, MMA urges NST Online What To Read Next...


hcai.ca.gov > affordability > hospital-fair-billing-program > hospital-bill-complaint-program

Hospital Bill Complaint Program

1+ mon, 1+ day ago   (480+ words) The Hospital Bill Complaint Program can also investigate complaints about a hospital’s failure to: The Hospital Bill Complaint Program does not have jurisdiction (authority) over general billing or fee disputes. You are eligible to apply for a hospital’s discount payment…...


medicaldaily.com > hhs-340b-analysis-costlier-drugs-hospital-consolidation-479805

340B Drug Discounts Reward Costlier Drugs and Hospital Consolidation, HHS Economists Argue as Medicare Cut Looms

43+ min ago   (897+ words) Economists at the U.S. Department of Health and Human Services argue that a federal drug discount program meant to help safety-net hospitals now gives hospitals financial reasons to overuse expensive drugs and expand through consolidation. The policy brief from the department's…...


pluang.com > en > asset > usstock > DGX > 10564

Quest Diagnostics Inc (DGX) Stock Price Today

4+ hour, 17+ min ago   (278+ words) Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network…...


russpain.com > news > johnson-and-johnson-faces-a-deepening-fight-over-trust-106375

Johnson & Johnson faces a deepening fight over trust

4+ hour, 14+ min ago   (738+ words) Gardiner Harris accuses Johnson & Johnson of lethal marketing and corruption. His book links major products to millions of deaths and a Spanish health scandal, while available sources do not independently confirm the estimate of two million deaths. Gardiner Harris estimates…...


staradvertiser.com > 10/09/2026 > hawaii-news > millions-lose-private-medicare-plans-and-face-rising-costs

Millions lose private Medicare plans and face rising costs

8+ hour, 52+ min ago   (1254+ words) Saturday, October 10, 2026 84° Today's Paper By Christopher Rowland and Reed Abelson / New York Times BRUCE OMORI/THE NEW YORK TIMES Mick and Ann Kalber, who are bracing to pay hundreds more in health insurance premiums after receiving a letter last week…...


theglobeandmail.com > investing > markets > stocks > NVCT > pressreleases > 3463251 > maxim-group-keeps-their-buy-rating-on-nuvectis-pharma-nvct

Maxim Group Keeps Their Buy Rating on Nuvectis Pharma (NVCT)

31+ min ago   (183+ words) In a report released yesterday, Naz Rahman from Maxim Group reiterated a Buy rating on Nuvectis Pharma, with a price target of $30.00. Rahman covers the Healthcare sector, focusing on stocks such as Nuvectis Pharma, Vertex Pharmaceuticals, and Vivani Medical. According…...


theglobeandmail.com > investing > markets > stocks > NVCT > pressreleases > 4443668 > some-of-the-top-biotech-funds-just-bought-into-this-under-the-radar-biotech-nasdaq-nvct

Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT)

31+ min ago   (189+ words) WSW, NY, September 3rd, 2026, FinanceWire NXP200, the second Haisco-licensed asset, is a next-generation, brain-penetrant BRAF inhibitor in Phase 1b development for BRAF-mutated cancers, including glioma, colorectal, and non-small cell lung cancer. In April 2026, Servier acquired Day One Biopharmaceuticals, whose sole approved product was…...